Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years by Chunlin Zhuang, Christophe Pannecouque, Erik De Clercq, Fener Chen

Connect to this object online.

Methodology of drug screening and target identification for new necroptosis inhibitors by Pengchao Pan, Zhenyu Cai, Chunlin Zhuang, Xiaofei Chen, Yifeng Chai

Connect to this object online.

Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy by Jing Zhu, Meng Xin, Congcong Xu, Yuan He, Wannian Zhang, Zhibin Wang, Chunlin Zhuang

Connect to this object online.

Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors by Kaijun Jin, Minjie Liu, Chunlin Zhuang, Erik De Clercq, Christophe Pannecouque, Ge Meng, Fener Chen

Connect to this object online.

Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library by Yu Zou, Yue Chai, Hongming Shao, Shuyu Wang, Ruilin Hou, Runhui Liu, Linjing Zhao, Chunlin Zhuang

Connect to this object online.

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment by Jiangtao Fu, Pingping Zhang, Zhiguo Sun, Guodong Lu, Qi Cao, Yiting Chen, Wenbin Wu, Jiabao Zhang, Chunlin Zhuang, Chunquan Sheng, Jiajun Xu, Ying Lu, Pei Wang

Connect to this object online.